首页> 外文期刊>Journal of Ethnopharmacology: An Interdisciplinary Journal Devoted to Bioscientific Research on Indigenous Drugs >Symplocos cochinchinensis enhances insulin sensitivity via the down regulation of lipogenesis and insulin resistance in high energy diet rat model
【24h】

Symplocos cochinchinensis enhances insulin sensitivity via the down regulation of lipogenesis and insulin resistance in high energy diet rat model

机译:Symplocos Cochinchinensis通过脂肪发生和高能量饮食大鼠模型的血液发生和胰岛素抵抗的调节增强了胰岛素敏感性

获取原文
获取原文并翻译 | 示例
           

摘要

Ethnopharmacological relevance: This plant has been utilized in Indian system of medicine for treatment of diabetes. This is clearly evident from the composition of Ayurvedic preparation for diabetes 'Nisakathakadi Kashayam' where this is one of the main ingredients of this preparation Aim of the study: The study aims in elucidating the molecular mechanisms underlying the insulin sensitizing effects of Symplocos cochinchinensis ethanol extract (SCE) using a high fructose and saturated fat (HFS) fed insulin resistant rat model. Materials and methods: Experimental groups consisted of normal diet (ND), ND+SCE 500 mg/kg bwd, HFS +vehicle, HFS+metformin 100 mg/kg bwd, HFS+SCE 250/500 mg/kg bwd. Initially the animals were kept under HFS diet for 8 weeks, and at the end of 8 week period, animals were found to develop insulin resistance and dyslipidemia. Post-administration of SCE, metformin or vehicle were carried out for 3 weeks. Gene and protein expressions relevant to insulin signalling pathway were analysed. Results: HFS significantly altered the normal physiology of animals via proteins and genes relevant to metabolism like stearoyl-CoA desaturase (SCD1), sterol regulatory element binding protein 1 (SREBP-lc), fatty acid synthase (FAS), glucose 6 phosphatase (G6Pase), phosphoenol pyruvate carboxykinase (PEPCK), glucose transporter 2 (GLUT2), protein tyrosine phosphatse 1B (PTP1B), peroxisome proliferator activated receptor alpha (PPAR alpha), sirtuin 1 (SIRT1) and glucokinase. SCE administration attenuates the insulin resistance in HFS rat by the down regulation of SCD1 gene expression that modulates SREBP-lc dependent and independent hepatic lipid accumulation. Conclusion: SCE enhances insulin sensitivity via the down regulation of lipogenesis and insulin resistance in HFS rat model.
机译:Ethnopharmacological相关性:这种植物已被用于治疗糖尿病的药物中印系统。这是从阿育吠陀制剂用于治疗糖尿病“Nisakathakadi Kashayam”,其中这是该制剂目的该研究的主要成分之一的组合物清楚地看到:本研究的目的是阐明底层矾鳖乙醇提取物的胰岛素增敏作用的分子机制使用高果糖和饱和脂肪(HFS)供给胰岛素抵抗大鼠模型(SCE)。材料和方法:实验组由正常饮食(ND)的,ND + SCE 500毫克/公斤BWD,HFS +车辆,HFS +二甲双胍100mg / kg的BWD,HFS + SCE 250/500毫克/千克BWD。最初的动物下HFS饮食保持8周,第8周期末,发现动物发展胰岛素抵抗和血脂异常。 SCE,二甲双胍或车辆的后期管理进行了3周进行。相关胰岛素信号通路的基因和蛋白的表达进行了分析。结果:HFS显著通过蛋白质和有关的像硬脂酰辅酶A去饱和酶(SCD1)代谢的基因改变的动物的正常生理,固醇调节元件结合蛋白1(SREBP-LC),脂肪酸合酶(FAS),葡萄糖6-磷酸酶(G6P酶),磷酸烯醇丙酮酸羧激酶(PEPCK),葡萄糖转运蛋白2(GLUT2),蛋白酪氨酸phosphatse酶1B(PTP1B),过氧化物酶体增殖激活受体α(PPAR的α),沉默调节蛋白1(SIRT1)和葡糖激酶。 SCE给药SCD1基因表达的下调该调制SREBP-LC依赖性和非依赖性肝脏脂质蓄积减弱HFS大鼠胰岛素抵抗。结论:SCE增强通过脂肪生成和胰岛素抵抗的HFS大鼠模型中下调胰岛素敏感性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号